Receptor Life Sciences Opens Second (IND) Application with FDA for RLS103
01 Nov 2022 //
BUSINESSWIRE
Receptor Life Sciences Begins Dosing with RLS103 in PIb/IIa Study in Anxiety
29 Jun 2022 //
BUSINESSWIRE
Receptor Life Sciences Secures $9.7M Financing to Advance RLS103 into Trials
07 Apr 2022 //
PRESS FELEASE
Receptor Life Sciences Announces FDA Acceptance of IND Application for RLS103
30 Mar 2022 //
BUSINESSWIRE
Receptor Life Sciences publishes its Clinical Pharmacokinetics Study of RLS103.
17 Aug 2021 //
BUSINESSWIRE
Receptor Announces Initiation of IND-Opening Clinical PK Study of RLS102
19 Jul 2021 //
BUSINESSWIRE
Receptor Life Announces Poster Presentations at the Respiratory Drug 2021
27 Apr 2021 //
BUSINESSWIRE